Table 3 Antithrombotic treatment in the protocol (n = 99) and non-protocol (n = 291) treated groups
Protocol, n (%) | Non-protocol, n (%) | P-value | |
|---|---|---|---|
First medical contact | |||
Aspirin | 99 (100) | 257 (88.3) | <0.0001 |
Prasugrel loading dose | 99 (100) | 139 (47.8) | <0.0001 |
Clopidogrel loading dose | 1(1.0) | 116 (39.9) | <0.0001 |
Enoxaparin bolus i.v. | 99 (100) | 192 (66.0) | <0.0001 |
Glycoprotein IIb/IIIa inhibitor | 0 (0) | 15 (5.2) | 0.021 |
Catheter laboratorio | |||
Bivalirudin | 99 (100) | 36 (12.4) | <0.0001 |
Glycoprotein IIb/IIIa inhibitor | 6 (6.1) | 79 (27.1) | <0.0001 |
Enoxaparin i.v. | 9 (9.1) | 56 (19.2) | 0.019 |
Unfractionated heparin | 0 (0) | 7 (2.4) | 0.119 |